Claire Le Manach Selected Research

alpha-aminopyridine

1/2018	UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.
1/2017	Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire Le Manach Research Topics

Disease

7	Malaria 01/2021 - 11/2016
1	Infections 10/2020

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 11/2020 - 01/2018
2	MMV390048IBA 01/2018 - 01/2017
2	alpha-aminopyridineIBA 01/2018 - 01/2017
1	octaneIBA 01/2021
1	SulfonesIBA 10/2020
1	imidazopyridineIBA 10/2018
1	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2017
1	2-aminopyrazineIBA 11/2016